Details of the Drug

General Information of Drug (ID: DMZ8AL8)

• Drug Name: BB3
• Synonyms: 3-(3,5-Dibromo-4-hydroxybenzoyl)-2-ethyl-N,N-dimethylbenzofuran-6-sulfonamide; 765317-71-3; 3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID DIMETHYLAMIDE; BB3; 3-(3,5-dibromo-4-hydroxybenzoyl)-2-ethyl-N,N-dimethyl-1-benzofuran-6-sulfonamide; SCHEMBL4320310; AC1L9M79; 1t48; ZINC14881085; AKOS025404898; DB04142; AK174884; N,N-Dimethyl-2-ethyl-3-(3,5-dibromo-4-hydroxybenzoyl)benzofuran-6-sulfonamide; 3-(3,5-dibromo-4-hydroxybenzoyl)-2-ethyl-N,N-dimethylbenzofuran -6-sulfonamide

Indication

Disease Entry	ICD 11	Status	REF
Cerebrovascular ischaemia	8B1Z	Phase 3	[1]
Congestive heart failure	BD10	Phase 3	[1]
Graft-versus-host disease	4B24	Phase 3	[2]

• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C19H17Br2NO5S
  Canonical SMILES: CCC1=C(C2=C(O1)C=C(C=C2)S(=O)(=O)N(C)C)C(=O)C3=CC(=C(C(=C3)Br)O)Br
  InChI: InChI=1S/C19H17Br2NO5S/c1-4-15-17(18(23)10-7-13(20)19(24)14(21)8-10)12-6-5-11(9-16(12)27-15)28(25,26)22(2)3/h5-9,24H,4H2,1-3H3
  InChIKey: FEYGJZKVMASWJB-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 448660
  DrugBank ID: DB04142
  TTD ID: D0MY7F
• Drug ADMET Endpoint Profile (DAE)NEW: Click to Jump to the Detailed DAE Information of This Drug
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] Clinical pipeline report, company report or official report of Angion Therapeutics.
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)